The Experts below are selected from a list of 291 Experts worldwide ranked by ideXlab platform
Mark A Fendrick - One of the best experts on this subject based on the ideXlab platform.
-
managed care Medical Technology and health care cost growth a review of the evidence
Medical Care Research and Review, 1998Co-Authors: Michael E. Chernew, Richard A. Hirth, Seema S Sonnad, Rachel Ermann, Mark A FendrickAbstract:Although managed care plans reduce health care expenditures at any point in time, less is known about whether such plans control health care cost growth. Because use of new Medical Technology is an important determinant of cost growth, the impact of managed care on utilization of Medical Technology will largely determine whether managed care can reduce expenditure growth to sustainable levels. This article reviews the literature relating Medical Technology to cost growth and the literature examining the impact of managed care on either cost growth or on the diffusion of Medical Technology. Studies that examine plan-level data often reach different conclusions than studies that examine market-level data. The evidence suggests that managed care, as currently practiced, may reduce the rate of cost growth. However, managed care is unlikely to prevent the share of gross domestic product spent on health care from rising unless the cost-increasing nature of new Technology changes.
M. Wong - One of the best experts on this subject based on the ideXlab platform.
-
Managing Medical Technology in Australia's Health Care Systems - Planning, Prioritisation and Procurement
Engineering in Medicine and Biology Society, 2006. EMBS '06. 28th Annual International Conference of the IEEE, 2006Co-Authors: I Brown, A. Smale, M. WongAbstract:The management of Medical Technology raises a range of complex issues including those associated with planning, prioritisation, and procurement. In Australia there is a significant and developing interest at National, State, and Hospital levels in issues relating to the effective management of Medical Technology, with drivers including service planning & cost management, access & equity, and factors associated with the ongoing use of old equipment. Surveys undertaken by the authors and reported elsewhere have now been used to develop a 5 year equipment replacement and procurement model to predict required funding levels. Survey data is also used to assist in the prioritisation of equipment and to identify centralised purchasing opportunities. The data also provides metrics to record the effectiveness of funding programs
-
Management of Medical Technology □ Implementation Issues
2005 IEEE Engineering in Medicine and Biology 27th Annual Conference, 2006Co-Authors: I Brown, A. Smale, M. WongAbstract:Medical Technology in Australian public hospitals has a replacement cost of approximately A$3 billion. The management of this invaluable asset suggests the need for a planning framework to facilitate equipment replacement and acquisition decisions, an accurate inventory of Technology assets, and an implementation process to enable prioritisation and the allocation of funds. The authors report on work associated with the initial phases of planning process development and identify issues that need to be resolved in relation to the implementation phase
-
The management of Medical Technology
The Seventh Australian and New Zealand Intelligent Information Systems Conference 2001, 2001Co-Authors: I Brown, A. Smale, M. WongAbstract:Medical Technology is a valuable asset that is strategically important to the operational efficiency of the Australian health care industry. This paper looks at the Australian care health industry and suggests the need for a more structured approach to Medical Technology strategic planning at a national, state, and hospital level. Strategic planning frameworks are considered and data relating to a sample of Australian hospitals is discussed. The paper deals with a wide range of issues that impact on Medical Technology strategic planning including cost of ownership, access and equity, remaining life of Technology, financing options, and centralised vs local planning.
Michael E. Chernew - One of the best experts on this subject based on the ideXlab platform.
-
managed care Medical Technology and health care cost growth a review of the evidence
Medical Care Research and Review, 1998Co-Authors: Michael E. Chernew, Richard A. Hirth, Seema S Sonnad, Rachel Ermann, Mark A FendrickAbstract:Although managed care plans reduce health care expenditures at any point in time, less is known about whether such plans control health care cost growth. Because use of new Medical Technology is an important determinant of cost growth, the impact of managed care on utilization of Medical Technology will largely determine whether managed care can reduce expenditure growth to sustainable levels. This article reviews the literature relating Medical Technology to cost growth and the literature examining the impact of managed care on either cost growth or on the diffusion of Medical Technology. Studies that examine plan-level data often reach different conclusions than studies that examine market-level data. The evidence suggests that managed care, as currently practiced, may reduce the rate of cost growth. However, managed care is unlikely to prevent the share of gross domestic product spent on health care from rising unless the cost-increasing nature of new Technology changes.
-
Managed care and Medical Technology: implications for cost growth.
Health Affairs, 1997Co-Authors: Michael E. Chernew, A M Fendrick, Richard A. HirthAbstract:Managed care health plans, particularly health maintenance organizations (HMOs), have been shown to reduce the level of health care spending. Their ability to constrain the long-term rate of health care cost growth is less certain and will depend largely on their ability to constrain the use of emerging Medical technologies. Evidence from experience with one important Medical Technology, laparoscopic cholecystectomy, suggests no systematic difference between HMOs and the general population in the rate of growth in utilization following the introduction of new Medical Technology.
P V Rosenau - One of the best experts on this subject based on the ideXlab platform.
-
Managing Medical Technology: Lessons for the united states from Quebec and France
International Journal of Health Services, 2000Co-Authors: P V RosenauAbstract:Important modifications to Technology assessment, diffusion, adoption, and utilization must take place if the United States is to better employ Medical Technology and save resources so as to assure access for the uninsured and underinsured. The United States can learn from other health systems that are more successful in achieving these goals. The author selects for comparison the health systems of France and Quebec. The discussion focuses on the differences between the three systems in the management of Medical Technology on a range of policy-relevant dimensions, including health system structure, attitudes about planning versus market competition, government regulation, the balance between decentralization and centralization, the needs of the individual and those of the society, linkages between Technology assessment and policy-making, and the importance of Medical Technology assessment for Medical practice. Seven specific recommendations are made for better managing Medical Technology in the United States, drawing on what can be observed from the experiences of Quebec and France.
I Brown - One of the best experts on this subject based on the ideXlab platform.
-
Managing Medical Technology in Australia's Health Care Systems - Planning, Prioritisation and Procurement
Engineering in Medicine and Biology Society, 2006. EMBS '06. 28th Annual International Conference of the IEEE, 2006Co-Authors: I Brown, A. Smale, M. WongAbstract:The management of Medical Technology raises a range of complex issues including those associated with planning, prioritisation, and procurement. In Australia there is a significant and developing interest at National, State, and Hospital levels in issues relating to the effective management of Medical Technology, with drivers including service planning & cost management, access & equity, and factors associated with the ongoing use of old equipment. Surveys undertaken by the authors and reported elsewhere have now been used to develop a 5 year equipment replacement and procurement model to predict required funding levels. Survey data is also used to assist in the prioritisation of equipment and to identify centralised purchasing opportunities. The data also provides metrics to record the effectiveness of funding programs
-
Management of Medical Technology □ Implementation Issues
2005 IEEE Engineering in Medicine and Biology 27th Annual Conference, 2006Co-Authors: I Brown, A. Smale, M. WongAbstract:Medical Technology in Australian public hospitals has a replacement cost of approximately A$3 billion. The management of this invaluable asset suggests the need for a planning framework to facilitate equipment replacement and acquisition decisions, an accurate inventory of Technology assets, and an implementation process to enable prioritisation and the allocation of funds. The authors report on work associated with the initial phases of planning process development and identify issues that need to be resolved in relation to the implementation phase
-
The management of Medical Technology
The Seventh Australian and New Zealand Intelligent Information Systems Conference 2001, 2001Co-Authors: I Brown, A. Smale, M. WongAbstract:Medical Technology is a valuable asset that is strategically important to the operational efficiency of the Australian health care industry. This paper looks at the Australian care health industry and suggests the need for a more structured approach to Medical Technology strategic planning at a national, state, and hospital level. Strategic planning frameworks are considered and data relating to a sample of Australian hospitals is discussed. The paper deals with a wide range of issues that impact on Medical Technology strategic planning including cost of ownership, access and equity, remaining life of Technology, financing options, and centralised vs local planning.
-
Teaching undergraduates Medical Technology innovation and business planning
The Seventh Australian and New Zealand Intelligent Information Systems Conference 2001, 2001Co-Authors: I BrownAbstract:This paper describes the curriculum and approach used to introduce undergraduate bioMedical engineering students to the process of Medical Technology innovation and business planning. Acknowledging that undergraduates may lack experience in relation to many of the issues that need to be dealt with in relation to the design, development and commercialisation of new Technology, the author has progressively used the Internet as a growing window to the world to enable students to build a knowledge base beyond their own experience. Like real first time innovators the students are expected to acquire the knowledge required to firstly generate new design concepts, then select the most Medically and commercially interesting design concept, establish IP management requirements, look at costs associated with R&D, product development and commercialisation, identify regulatory requirements, assess competition, and then analyse cost and profit. The classroom teaching is based on recent Australian Technology case studies and the innovation focus is concentrated in a prescribed area of Medical Technology. The desired outcome is a knowledge of the issues that either assist or inhibit the development of new Medical Technology and insights into the innovation process. Each undergraduate student develops a business plan for the development of a new Medical device.